TBPH compared with SITC: revenue, margins and what each company keeps, and the suppliers and customers both name

TBPHTheravance Biopharma, Inc.

Mkt capRevenueRevenue

SITCSITE Centers Corp.

Mkt capRevenueRevenue

Compare

TBPHTheravance Biopharma, Inc.

SITCSITE Centers Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TBPH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 10 '26±6.0%▼−0.12%×0.02

May 7 '26±10.3%▲+0.47%×0.05

Mar 19 '26±12.0%▲+1.30%×0.11

Nov 11 '25±24.6%▲+22.68%×0.92

SITC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26±33.0%0.00%×0.00

Aug 4 '26±18.2%▼−4.23%×0.23

= impliedTBPH realized, solidSITC realized, hatchedOne scale, both sides: full bar = 43%× = |realized| ÷ impliedSource: market data

May 8 '26

±25.4%

▼−0.89%

×0.04

Feb 27 '26±42.1%▼−8.74%×0.21

TBPHTheravance Biopharma, Inc.

17.03▲+0.02%· post 17.04

Mkt cap$884.2MRevenue$21MQ2 FY26Revenue$107MFY25

SITCSITE Centers Corp.

0.67▲+17.18%· post 0.67

ClosedNov 6 '26

Mkt cap$35.1MRevenue$12MQ3 FY26Revenue$501MFY25

Compare

ClosedNov 6 '26

TBPHTheravance Biopharma, Inc.

SITCSITE Centers Corp.

17.03▲+0.02%post 17.04

Price

0.67▲+17.18%post 0.67

$884.2M

Mkt cap

$35.1M

Q2 FY26$21M

Revenue

$12MQ3 FY26

FY25$107M

Revenue

$501MFY25

TBPH17.03▲+0.02%vsSITC0.67▲+17.18%ClosedNov 6 '26